(Reuters) – Europe’s medicines regulator on Thursday set up an exceptional meeting for Jan. 6 to assess the marketing authorisation application for Moderna’s COVID-19 vaccine.
EMA had earlier planned to meet on Jan. 12 to review the application.
(Reporting by Yadarisa Shabong in Bengaluru; Editing by Anil D’Silva)
